Inside This Issue: Climate & Malaria, AI in Cancer Screening, Rising Pediatric Obesity, and More
The Growing Threat: Extreme Weather as a Critical Barrier to Malaria Elimination
Successive tropical cyclones are crippling malaria control in high-burden regions—damaged infrastructure disrupts indoor spraying, medicine shortages delay treatment, and standing water multiplies mosquito breeding. The result? Dangerous spikes in infections. This is climate change in action—its impact on health and disease transmission is no longer theoretical. Read More...
Advancing Colorectal Cancer Screening: Precision Through AI Customization
Standard guidelines provide a strong baseline, but real-world variables—like local cancer rates, patient diversity, and regional reimbursement policies—often go unaddressed. Without adaptive screening protocols, early detection suffers, especially in high-risk or underserved communities. It's time for smarter, more responsive strategies. Read More...
The Escalating Crisis of Severe Pediatric Obesity—and What We Can Do About It
New data show not just more children affected by obesity, but more severe cases emerging. As extreme phenotypes become more common, today’s diagnostic categories and management protocols are falling short. It’s time to evolve how we identify and treat pediatric obesity. Read More...
Live Education Events: Learn with the Experts
Back to Live CME at WHAV 2025
Nothing beats face-to-face learning—and we’re bringing it back with #WHAV2025.
Join Barbara Dehn and Anita Nelson, MD live in New York City on September 20 for expert-led education, real-time clinical insights, and the kind of connection you can’t replicate online.
Featured Episodes
Advancing FSGS Care with Sparsentan
Why listen: This episode breaks down pivotal clinical trial data from the DUET and DUPLEX trials - two studies comparing sparsentan and irbesartan in patients with FSGS.
Key highlights:
DUET: 25% of patients on sparsentan achieved partial remission vs. 9% on irbesartan
DUPLEX: Sustained proteinuria reduction + less eGFR decline at 2 years
Join Dr. Kenneth Lieberman (Hackensack Meridian Health) and Dr. Howard Trachtman (University of Michigan) to learn more.
Beyond the Skin: Psoriasis & Cardiovascular Risk—What Clinicians Need to Know
Why listen: This powerful conversation dives into the critical link between inflammatory skin disease and cardiovascular health, hosted by Dr. Mary Katherine Cheeley with Dr. Joel Gelfand (University of Pennsylvania) and Dr. Michael Garshick (NYU Langone Health).
You'll learn this and more:
How psoriasis and atherosclerosis share inflammatory pathways
Why psoriasis may be a marker - or even a contributor - to cardiovascular risk
When and how dermatologists should screen for diabetes, hypertension, and lipid disorders
Specialty Focus
HEMATOLOGY: Can Inflammation Control Boost Gene Therapy in Sickle Cell Disease?
ENDOCRINOLOGY: Survey Insights: Endocrine Challenges in DMD Management
INFECTIOUS DISEASE: What We Know About Pediatric COVID-19 Responses (So Far)
OPHTHALMOLOGY: 7 Public Health Strategies That Could Slow the Myopia Surge
SURGERY: How to Prevent Postsurgical Wound Complications & Improve Healing Outcomes
Thank you for reading ReachMD Review! If this brought you value, react below - and subscribe to get next week's issue.
Be part of the knowledge with ReachMD.